Our manufacturing team is key to our mission, advancing Afib treatment and post-op pain management through their exceptional work. Watch Senior Principal Model Designer, Adam Harp, for an exclusive behind-the-scenes look at AtriCure’s manufacturing. <a href="https://twitter.com/hashtag/MFGDay2024?src=hashtag_click&quot; target="_blank">#MFGDay2024</a>

At <a href='https://www.linkedin.com/feed/hashtag/?keywords=APHRS2024&highlightedUp…; target='_blank'>#APHRS2024</a>, the CEASE-AF 24-month results were presented. The data demonstrated that Hybrid ablation with left atrial appendage exclusion is effective over the long term, with a ~33% absolute improvement in freedom from atrial arrhythmias* after 24 months of follow-up in patients with long-standing persistent Afib.**​
​
Learn more about the CEASE AF Trial data: <a href="https://okt.to/cKo4mY&quot; target="_blank">https://okt.to/cKo4mY</a&gt;
​
​
*Freedom from atrial arrhythmias (atrial fibrillation, atrial flutter, atrial tachycardia) off anti-arrhythmic drugs (AADs) except previously failed AADs at doses not exceeding those previously failed​​
**Persistent atrial fibrillation with enlarged left atrium and longstanding persistent Afib​​

Introducing the AtriClip® FLEX-Mini™ device. The latest addition to our AtriClip® family features a closed-ended design that is 60% smaller than the next lowest profile clip on the market. ​
​
Learn more:<a href="https://t.co/jhBp6lj7ih&quot; target="_blank">https://t.co/jhBp6lj7ih</a&gt;

Introducing the AtriClip® FLEX-Mini™ device. The third-generation and latest addition to our AtriClip® family, it features a closed-ended design that's 60% smaller than the next lowest profile clip on the market – all while maintaining continual parallel closing pressure and stability that AtriClip devices are known for.​
​
Learn how the FLEX-Mini could elevate your practice: <a href="https://okt.to/nTWM6C&quot; target="_blank">https://okt.to/nTWM6C</a&gt;

Patients with Inappropriate Sinus Tachycardia (IST) often experience symptoms that significantly impact their quality of life. For those who don’t respond to or are intolerant to medications, the HEAL-IST clinical trial is evaluating a new hybrid ablation procedure as a potential treatment.​
​
Learn more about the study: heal-ist.com​
​
<a href='https://www.linkedin.com/feed/hashtag/?keywords=ClinicalTrial&highlight…; target='_blank'>#ClinicalTrial</a> <a href='https://www.linkedin.com/feed/hashtag/?keywords=IST&highlightedUpdateUr…; target='_blank'>#IST</a> <a href='https://www.linkedin.com/feed/hashtag/?keywords=Innapropriatesinustachy…; target='_blank'>#Innapropriatesinustachycardia</a>​
​

Great start to the day at <a href="https://twitter.com/MSUMD&quot; target="_blank">@MSUMD</a>'s Grand Rounds, sharing insights on advances in AF treatment with a room full of doctors, pharmacists, residents, &amp; medical students. Also appreciated additional valuable conversations with <a href="https://twitter.com/CorewellHealth&quot; target="_blank">@CorewellHealth</a> surgeons about Afib &amp; cardiac surgery.

In a retrospective analysis sponsored by AtriCure, healthcare systems saved an average of $8,601 in total healthcare costs for lobectomy patients who received Cryo Nerve Block (ablation) for post-op pain management compared to those who did not. ​

Learn more:… <a href="https://t.co/FljiwKEfuS&quot; target="_blank">https://t.co/FljiwKEfuS</a&gt;

In a retrospective analysis sponsored by AtriCure, healthcare systems saved an average of $8,601 in total healthcare costs for lobectomy patients who received Cryo Nerve Block (ablation) for post-op pain management compared to those who did not. ​

Learn more about the device reducing hospital system costs and relieving post-op pain at: <a href="https://okt.to/auKl0L&quot; target="_blank">https://okt.to/auKl0L</a&gt;

We're excited to share the Isolator® Synergy™ EnCompass® Clamp has received regulatory approval in CE-marked countries in Europe!

The EnCompass clamp provides a simpler and faster approach to ablating the heart in open-chest procedures.

Read the full release to learn more:… <a href="https://t.co/gouR2Xny4E&quot; target="_blank">https://t.co/gouR2Xny4E</a&gt;

Over the past two years, the EnCompass Clamp has made a real impact in advancing treatment alongside cardiac surgery in the U.S. We're eager to bring this innovative therapy to patients &amp; physician partners in Europe, expanding our international line.